| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 31724* | 2014 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 28520* | 2016 |
| Prasugrel versus clopidogrel in patients with acute coronary syndromes SD Wiviott, E Braunwald, CH McCabe, G Montalescot, W Ruzyllo, ... New England Journal of Medicine 357 (20), 2001-2015, 2007 | 8312 | 2007 |
| Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ... Circulation 123 (23), 2736-2747, 2011 | 4447 | 2011 |
| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3444 | 2020 |
| Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ... New England Journal of Medicine 352 (12), 1179-1189, 2005 | 2928 | 2005 |
| TIMI frame count: a quantitative method of assessing coronary artery flow CM Gibson, CP Cannon, WL Daley, JT Dodge Jr, B Alexander, SJ Marble, ... Circulation 93 (5), 879-888, 1996 | 2706 | 1996 |
| Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban CP Cannon, WS Weintraub, LA Demopoulos, R Vicari, MJ Frey, N Lakkis, ... New England Journal of Medicine 344 (25), 1879-1887, 2001 | 2597 | 2001 |
| Rivaroxaban in patients with a recent acute coronary syndrome JL Mega, E Braunwald, SD Wiviott, JP Bassand, DL Bhatt, C Bode, ... New England Journal of Medicine 366 (1), 9-19, 2012 | 2503 | 2012 |
| Prevention of bleeding in patients with atrial fibrillation undergoing PCI CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ... New England Journal of Medicine 375 (25), 2423-2434, 2016 | 1722 | 2016 |
| Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction CP Cannon, CM Gibson, CT Lambrew, DA Shoultz, D Levy, WJ French, ... Jama 283 (22), 2941-2947, 2000 | 1638 | 2000 |
| Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised … G Montalescot, SD Wiviott, E Braunwald, SA Murphy, CM Gibson, ... The Lancet 373 (9665), 723-731, 2009 | 1402 | 2009 |
| The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis TD Henry, BH Annex, GR McKendall, MA Azrin, JJ Lopez, FJ Giordano, ... Circulation 107 (10), 1359-1365, 2003 | 1380 | 2003 |
| Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs CM Gibson, CP Cannon, SA Murphy, KA Ryan, R Mesley, SJ Marble, ... Circulation 101 (2), 125-130, 2000 | 1241 | 2000 |
| Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide MS Sabatine, DA Morrow, JA de Lemos, CM Gibson, SA Murphy, N Rifai, ... Circulation 105 (15), 1760-1763, 2002 | 1051 | 2002 |
| Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial EM Antman, RP Giugliano, CM Gibson, CH McCabe, P Coussement, ... Circulation 99 (21), 2720-2732, 1999 | 1004 | 1999 |
| Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study MS Sabatine, CP Cannon, CM Gibson, JL López-Sendón, G Montalescot, ... Jama 294 (10), 1224-1232, 2005 | 977 | 2005 |
| Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy RH Chan, BJ Maron, I Olivotto, MJ Pencina, GE Assenza, T Haas, ... Circulation 130 (6), 484-495, 2014 | 969 | 2014 |
| Andexanet alfa for acute major bleeding associated with factor Xa inhibitors SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ... New England Journal of Medicine 375 (12), 1131-1141, 2016 | 954 | 2016 |
| Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk P Urban, R Mehran, R Colleran, DJ Angiolillo, RA Byrne, D Capodanno, ... Circulation 140 (3), 240-261, 2019 | 947 | 2019 |
Christopher P. CannonProfessor of Medicine, Harvard Medical School, Brigham and Women's HospitalVerificeret mail på bwh.harvard.edu
